New app aims to help type 1 diabetes patients exercise safely

NCT ID NCT06730906

ENROLLING_BY_INVITATION Symptom relief Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a smartphone app called PACTAID in 20 adults with type 1 diabetes. The app gives real-time advice during exercise to help keep blood sugar levels stable while using an automated insulin pump. Researchers will check if the app improves glucose control during and after workouts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PACTAID App (smartphone application)
What this could lead to: If it works, this app could help people with type 1 diabetes better control their blood sugar during and after exercise, reducing risk of highs and lows.
What could go wrong: This is a very small early study with only 20 participants, so results may not apply to everyone. The app is still being tested and refined, so it may not work as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES MELLITUS

Contacts and locations

Locations

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.